medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Número 5

<< Anterior

Rev Invest Clin 2017; 69 (5)


Histology as Prognostic Factor in Early-Stage Cervical Carcinoma. Experience in a Third-Level Institution

Barquet-Muñoz SA, Cruz-Rodríguez E, Cantú LDF, Isla-Ortiz D, Montalvo-Esquivel G, Herrera-Montalvo LA, Pérez-Plasencia C, Pérez-Montiel D, Herrera-Gómez Á

Idioma: Ingles.
Referencias bibliográficas: 18
Paginas: 286-292
Archivo PDF: 91.87 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. Lyon, France: IARC Cancer, Base; 2013. p. 11.

  2. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24-year population-based study. Gynecol Oncol. 2000;78:97-105.

  3. Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: A 35-year population-based analysis. J Womens Health (Larchmt). 2012;21:1031-7.

  4. Ries LA, Melbert D, Krapcho M. SEER. Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute; 2006. Available from: http://www.seer.cancer.gov/csr/1975_2004. [Last accessed on 2015 Oct 03].

  5. Irie T, Kigawa J, Minagawa Y, et al. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Eur J Surg Oncol. 2000;26:464-7.

  6. Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2000;79:289-93.

  7. Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecol Oncol. 2012;125:292-6.

  8. Lee YY, Choi CH, Kim TJ, et al. A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA. Gynecol Oncol. 2011;120: 439-43.

  9. Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix. Br J Cancer. 2010;102:1692-8.

  10. Ioffe OB. The uterine cervix. In: Silverberg SG, DeLellis RA, Frable WJ, LiVolsi VA, Wick MR, editors. Principles and Practice of Surgical Pathology and Cytopathology. Philadelphia, PA: Churchill Livingstone; 2006. p. 542-95.

  11. Kleine W, Rau K, Schwoeorer D, Pfleiderer A. Prognosis of the adenocarcinoma of the cervix uteri: A comparative study. Gynecol Oncol. 1989;35:145-9.

  12. Lee KB, Lee JM, Park CY, Lee KB, Cho HY, Ha SY. What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study. Int J Gynecol Cancer. 2006;16:1569-73.

  13. Wells M, Oslor AG, Crum CP, et al. Tumors of uterine cervix. In: Tavassoli FA, Stratton MR, editors. Pathology and Genetics: Tumours of the Breast and Female Genital Organs. Lyon: WHO; 2003. p. 259-89.

  14. Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC. Changing demographics of cervical cancer in the United States (1973-2008). Gynecol Oncol. 2012;126:330-3.

  15. Koh WJ, Greer BE, Abu-Rustum NR, et al. Cervical cancer. J Natl Compr Canc Netw. 2013;11:320-43.

  16. Galic V, Herzog TJ, Lewin SN, et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol. 2012;125:287-91.

  17. Shingleton HM, Bell MC, Fremgen A, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 1995;76 10 Suppl:1948-55.

  18. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol. 1995;59:38-44.




2020     |     www.medigraphic.com